Citius Oncology, Inc. CTOR Payments to Acquire Intangible Assets
Payments to Acquire Intangible Assets at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s payments to acquire intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s payments to acquire intangible assets?
- Citius Oncology, Inc. (CTOR) reported payments to acquire intangible assets of $600K in Q1 2026.
- How has Citius Oncology, Inc.'s payments to acquire intangible assets changed year-over-year?
- Citius Oncology, Inc.'s payments to acquire intangible assets decreased by 58.3% year-over-year, from $1.44M to $600K.
- What does payments to acquire intangible assets mean?
- Represents cash outflows for the purchase or development of non-physical assets such as patents, licenses, or intellectual property. This is a key indicator of a company's investment in long-term growth and competitive positioning through innovation.